ArticleFrontiers in human neuroscience2017
Prediction of Mild Cognitive Impairment Conversion Using a Combination of Independent Component Analysis and the Cox Model.
Article in Frontiers in human neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 1 synthesis or guideline pooled it, 80 citations in OpenAlex.
- Diagnostic performance of molecular imaging methods in predicting the progression from mild cognitive impairment to dementia: an updated systematic review.European journal of nuclear medicine and molecular imaging · 2024Pooled it
- Predicting progression of Alzheimer's disease using blood-based multi-omics data.Bioinformatics advances · 2026Article
- Article
- Early detection of Alzheimer's disease progression: comparative evaluation of deep learning models.Scientific reports · 2025Article
- Prevalence of Chronic Diseases by Cognitive Function Level and Age Group Among Middle-Aged and Older Korean Adults.International journal of geriatric psychiatry · 2025Article
- Alzheimer's disease risk prediction using machine learning for survival analysis with a comorbidity-based approach.Scientific reports · 2025Article
- Early Alzheimer's Disease Detection: A Review of Machine Learning Techniques for Forecasting Transition from Mild Cognitive Impairment.Diagnostics (Basel, Switzerland) · 2024Review
- Predicting Progression to Clinical Alzheimer's Disease Dementia Using the Random Survival Forest.Journal of Alzheimer's disease : JAD · 2023Article
- Predicting time-to-conversion for dementia of Alzheimer's type using multi-modal deep survival analysis.Neurobiology of aging · 2023Article
- Regularized Buckley-James method for right-censored outcomes with block-missing multimodal covariates.Stat (International Statistical Institute) · 2022Article
- Deep multiview learning to identify imaging-driven subtypes in mild cognitive impairment.BMC bioinformatics · 2022Article
- Developing a Cross-National Disability Measure for Older Adult Populations across Korea, China, and Japan.International journal of environmental research and public health · 2022Article
- Combining PET with MRI to improve predictions of progression from mild cognitive impairment to Alzheimer's disease: an exploratory radiomic analysis study.Annals of translational medicine · 2022Article
- A robust and interpretable machine learning approach using multimodal biological data to predict future pathological tau accumulation.Nature communications · 2022Article
- Predictive classification of Alzheimer's disease using brain imaging and genetic data.Scientific reports · 2022Article
- The Coupled Representation of Hierarchical Features for Mild Cognitive Impairment and Alzheimer's Disease Classification.Frontiers in neuroscience · 2022Article
- Alzheimer's Disease Prediction Algorithm Based on Group Convolution and a Joint Loss Function.Computational and mathematical methods in medicine · 2022Article
- Bridging structural MRI with cognitive function for individual level classification of early psychosisFrontiers in psychiatry · 2022Article
- A Tensorized Multitask Deep Learning Network for Progression Prediction of Alzheimer's Disease.Frontiers in aging neuroscience · 2022Article
- Artificial Intelligence for Alzheimer's Disease: Promise or Challenge?Diagnostics (Basel, Switzerland) · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
Abstract
Mild cognitive impairment (MCI) represents a transitional stage from normal aging to Alzheimer's disease (AD) and corresponds to a higher risk of developing AD. Thus, it is necessary to explore and predict the onset of AD in MCI stage. In this study, we propose a combination of independent component analysis (ICA) and the multivariate Cox proportional hazards regression model to investigate promising risk factors associated with MCI conversion among 126 MCI converters and 108 MCI non-converters from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. Using structural magnetic resonance imaging (MRI) and fluorodeoxyglucose positron emission tomography (FDG-PET) data, we extracted brain networks from AD and normal control groups via ICA and then constructed Cox models that included network-based neuroimaging factors for the MCI group. We carried out five separate Cox analyses and the two-modality neuroimaging Cox model identified three significant network-based risk factors with higher prediction performance (accuracy = 73.50%) than those in either single-modality model (accuracy = 68.80%). Additionally, the results of the comprehensive Cox model, including significant neuroimaging factors and clinical variables, demonstrated that MCI individuals with reduced gray matter volume in a temporal lobe-related network of structural MRI [hazard ratio (HR) = 8.29E-05 (95% confidence interval (CI), 5.10E- 07 ~ 0.013)], low glucose metabolism in the posterior default mode network based on FDG-PET [HR = 0.066 (95% CI, 4.63E-03 ~ 0.928)], positive apolipoprotein E ε4-status [HR = 1. 988 (95% CI, 1.531 ~ 2.581)], increased Alzheimer's Disease Assessment Scale-Cognitive Subscale scores [HR = 1.100 (95% CI, 1.059 ~ 1.144)] and Sum of Boxes of Clinical Dementia Rating scores [HR = 1.622 (95% CI, 1.364 ~ 1.930)] were more likely to convert to AD within 36 months after baselines. These significant risk factors in such comprehensive Cox model had the best prediction ability (accuracy = 84.62%, sensitivity = 86.51%, specificity = 82.41%) compared to either neuroimaging factors or clinical variables alone. These results suggested that a combination of ICA and Cox model analyses could be used successfully in survival analysis and provide a network-based perspective of MCI progression or AD-related studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.